Location History:
- Gujarat, IN (2011 - 2016)
- Ahmedabad, IN (2013 - 2018)
Company Filing History:
Years Active: 2011-2018
Title: The Innovative Contributions of Sanjeev Kumar Mendiratta
Introduction
Sanjeev Kumar Mendiratta, based in Gujarat, India, is a prominent inventor with a commendable portfolio of nine patents. His work primarily focuses on advancements in pharmaceutical formulations and monoclonal antibody purification processes.
Latest Patents
Among his latest patents is the invention concerning "Pharmaceutical formulations of TNF-alpha antibodies." This innovation presents improved formulations that utilize specific excipients to stabilize antibody preparations, while also preventing the formation of aggregates or fragments in solution. Another significant patent is for a "Purification process for monoclonal antibodies." This pioneering method offers an enhanced approach to purifying monoclonal antibodies from cell culture, utilizing affinity, hydrophobic interaction, and ion exchange column chromatography. This process achieves over 99% purity of the desired monoclonal antibody.
Career Highlights
Currently, Sanjeev is associated with Cadila Healthcare Limited, a leading pharmaceutical company known for its commitment to innovative healthcare solutions. Throughout his career, he has contributed significantly to the fields of biopharmaceutical development and protein engineering, leading to substantial advancements in therapeutic products.
Collaborations
Sanjeev has collaborated with talented coworkers, including Sanjay Bandyopadhyay and Vibhor Saraswat. Their joint efforts have played a crucial role in driving forward the innovations in pharmaceutical sciences and have greatly benefited the research and development initiatives within the company.
Conclusion
Sanjeev Kumar Mendiratta's advancements in pharmaceutical formulations and monoclonal antibody purification mark him as a key contributor in the field of biotechnology. His innovative approaches not only enhance the efficacy of therapeutic products but also pave the way for future research and inventions in the pharmaceutical industry.